Abstract

Hyaluronic acid (HA) is a polysaccharide found in the extracellular matrix of vertebrate epithelial, neural and connective tissues. Due to the high moisture retention, biocompatibility and viscoelasticity properties of this polymer, HA has become an important component of major pharmaceutical, biomedical and cosmetic products with high commercial value worldwide. Currently, large scale production of HA involves extraction from animal tissues as well as the use of bacterial expression systems in Streptococci. However, due to concerns over safety, alternative sources of HA have been pursued which include the use of endotoxin-free microorganisms such as Bacilli and Escherichia coli. In this review, we explore current knowledge of biosynthetic enzymes that produce HA, how these systems have been used commercially to produce HA and how the challenges of producing HA cheaply and safely are being addressed.

Highlights

  • Hyaluronic acid (HA) is a polysaccharide found in the extracellular matrix of vertebrate epithelial, neural and connective tissues

  • We explore current knowledge of biosynthetic enzymes that produce HA, how these systems have been used commercially to produce HA and how the challenges of producing HA cheaply and safely are being addressed

  • Hyaluronic acid (HA) is a linear glycosaminoglycan polymer commonly found in the extracellular matrix of vertebrate epithelial, neural and connective tissues

Read more

Summary

Introduction

Hyaluronic acid (HA) is a linear glycosaminoglycan polymer commonly found in the extracellular matrix of vertebrate epithelial, neural and connective tissues It is involved in many signalling pathways including those involved in embryonic development, wound healing, inflammation and cancer (Stern et al 2006). There are two production processes employed to obtain HA polymer in commercial quantities: extraction from animal tissues, typically rooster combs, or more recently though the application of bacterial expression systems in Streptococcus. Both approaches have faced considerable concerns over the safety of using biomedical products derived either from animal products or

67 Page 2 of 9
67 Page 4 of 9
67 Page 6 of 9
67 Page 8 of 9
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.